ALS (ASX:ALQ) set to acquire Investiga

Company News

by Rachael Jones

Global inspection business ALS (ASX:ALQ) today announced the acquisition of Investiga, a pharmaceutical testing business in Brazil and the USA.

Founded in 1993, Investiga is privately owned with 360 employees and generated $20 million of revenue in FY20.

It specialises in the cosmetic and personal care market.

Investiga will be integrated into the existing ALS Life Sciences network with a particular focus on growing in the USA, which represents over a quarter of the global market.

Shares in ALS (ASX:ALQ) are trading 3.79 per cent higher at $9.85.
 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.